Folyóiratcikkek tallózása szerző szerint "SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika"

A találatok rendezése: Rendezés: Találatok:

  • Veres, Amarilla; Szamosi, Tamás; Ablonczy, Mária; Szamosi, Tamás; Singh M; Karádi, István; Romics, László; Füst, György; Prohászka, Zoltán (2002)
    Background: Several groups have reported high levels of antibodies against 60 kDa heat shock proteins (hsp) associated with coronary heart disease. Methods and results: Complement activating (CA) antihsp60 autoantibodies ...
  • Haltrich, Irén; Piko, Henriett; Pamjav H; Somogyi, Anikó; Volgyi A; David D; Beke, Artúr; Garamvölgyi, Zoltán; Kiss, Eszter; Karcagi V; Fekete, György (2015)
    BACKGROUND: Turner syndrome, a congenital condition that affects 1/2,500 births, results from absence or structural alteration of the second sex chromosome. Turner syndrome is usually associated with short stature, gonadal ...
  • Kure S; Kato K; Dinopoulos A; Gail C; DeGrauw TJ; Christodoulou J; Bzduch V; Kálmánchey, Rozália; Fekete, György; Trojovsky A; Plecko B; Breningstall G; Tohyama J; Aoki Y; Matsubara Y (2006)
    Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism characterized by accumulation of glycine in body fluids and various neurological symptoms. NKH is caused by deficiency of the glycine cleavage multi-enzyme ...
  • Bartha, Á; Győrffy, Balázs (2019)
    Whole exome sequencing (WES) enables the analysis of all protein coding sequences in the human genome. This technology enables the investigation of cancer-related genetic aberrations that are predominantly located in the ...
  • Kiss, Richárd; Gángó, Ambrus; Benard-Slagter, Anne; Egyed, Bálint; Haltrich, Irén; Hegyi, Lajos; de Groot, Karel; Király, Péter Attila; Krizsán, Szilvia; Kajtár, Béla; Pikó, Henriett; Pajor, László; Vojcek, Ágnes; Matolcsy, András; Kovács, Gábor; Szuhai, Károly; Savola, Suvi; Bödör, Csaba; Alpár, Donát (2019)
  • Enders FB; Bader-Meunier B; Baildam E; Constantin, Tamás; Dolezalova P; Feldman BM; Lahdenne P; Magnusson B; Nistala K; Ozen S; Pilkington C; Ravelli A; Russo R; Uziel Y; van Brussel M; van der Net J; Vastert S; Wedderburn LR; Wulffraat N; McCann LJ; van Royen-Kerkhof A (2017)
    BACKGROUND: In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children ...
  • Zulian, Francesco; Culpo, Roberta; Sperotto, Francesca; Anton, Jordi; Avcin, Tadej; Baildam, Eileen M; Boros, Christina; Chaitow, Jeffrey; Constantin, Tamàs; Kasapcopur, Ozgur; Knupp Feitosa de Oliveira, Sheila; Pilkington, Clarissa A; Russo, Ricardo; Toplak, Natasa; van Royen, Annet; Saad Magalhães, Claudia; Vastert, Sebastiaan J; Wulffraat, Nico M; Foeldvari, Ivan (2019)
    In 2012, a European initiative called Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young ...
  • Teleki Ivett; Szász Attila Marcell; Maros Előd Máté; Györffy Balázs; Kulka Janina; Meggyesházi Nóra; Kiszner Gergő; Balla Péter; Samu Aliz; Krenács Tibor (2014)
    BACKGROUND AND AIMS: Connexins and their cell membrane channels contribute to the control of cell proliferation and compartmental functions in breast glands and their deregulation is linked to breast carcinogenesis. Our ...
  • Johann PD; Hovestadt V; Thomas C; Jeibmann A; Hess K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser, Péter; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Fruhwald MC; Kool M; Hasselblatt M (2017)
    Rhabdoid phenotype and loss of SMARCB1 expression in a brain tumor are characteristic features of atypical teratoid/rhabdoid tumors (ATRT). Rare non-rhabdoid brain tumors showing cribriform growth pattern and SMARCB1 loss ...
  • Veres, Gábor; Szabó, Dolóresz; Herczegné Várkonyi, Ágnes; Tari B; Polgar M; B Kovacs J; Horvath A; Tomsits, Erika; Tokodi I; Bodánszky, Hedvig; Dezsőfi, Antal; Szakos E; Vass, Noémi; Ruszinko V; Kovács, Márta; Müller, Katalin Eszter; Arató, András (2010)
    Infliximab, the chimeric antibody to tumor necrosis factor-alpha, is indicated for medically refractory pediatric Crohn disease. Aim of our study was to examine the efficacy and side effects of infliximab therapy in Hungarian ...
  • Szász, A Marcell; Lánczky A; Nagy, Ádám; Förster S; Hark K; Green JE; Boussioutas A; Busuttil R; Szabó, András; Győrffy, Balázs (2016)
    INTRODUCTION: Multiple gene expression based prognostic biomarkers have been repeatedly identified in gastric carcinoma. However, without confirmation in an independent validation study, their clinical utility is limited. ...
  • Pongor, Lőrinc; Munkácsy, Gyöngyi; Vereczkey, I; Pete, Imre; Győrffy, Balázs (2020)
    Tumor heterogeneity is a consequence of clonal evolution, resulting in a fractal-like architecture with spatially separated main clones, sub-clones and single-cells. As sequencing an entire tumor is not feasible, we ask ...
  • Shih, DJ; Northcott, PA; Remke, M; Korshunov, A; Ramaswamy, V; Kool, M; Luu, B; Yao, Y; Wang, X; Dubuc, AM; Garzia, L; Peacock, J; Mack, SC; Wu, X; Rolider, A; Morrissy, AS; Cavalli, FM; Jones, DT; Zitterbart, K; Faria, CC; Schuller, U; Kren, L; Kumabe, T; Tominaga, T; Shin, Ra Y; Garami, Miklós; Hauser, Péter; Chan, JA; Robinson, S; Bognár, László; Klekner, Álmos; Saad, AG; Liau, LM; Albrecht, S; Fontebasso, A; Cinalli, G; De Antonellis, P; Zollo, M; Cooper, MK; Thompson, RC; Bailey, S; Lindsey, JC; Di Rocco, C; Massimi, L; Michiels, EM; Scherer, SW; Phillips, JJ; Gupta, N; Fan, X; Muraszko, KM; Vibhakar, R; Eberhart, CG; Fouladi, M; Lach, B; Jung, S; Wechsler-Reya, RJ; Fevre-Montange, M; Jouvet, A; Jabado, N; Pollack, IF; Weiss, WA; Lee, JY; Cho, BK; Kim, SK; Wang, KC; Leonard, JR; Rubin, JB; de Torres, C; Lavarino, C; Mora, J; Cho, YJD; Tabori, U; Olson, JM; Gajjar, A; Packer, RJ; Rutkowski, S; Pomeroy, SL; French, PJ; Kloosterhof, NK; Kros, JM; Van, Meir EG; Clifford, SC; Bourdeaut, F; Delattre, O; Doz, FF; Hawkins, CE; Malkin, D; Grajkowska, WA; Perek-Polnik, M; Bouffet, E; Rutka, JT; Pfister, SM; Taylor, M (2014)
    PURPOSE: Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group 3, and Group 4. Current medulloblastoma protocols stratify patients based on clinical features: patient age, metastatic stage, extent ...
  • Santarpia L; Bottai G; Kelly CM; Győrffy, Balázs; Székely, Borbála; Pusztai L (2016)
    : Advances in DNA and RNA sequencing revealed substantially greater genomic complexity in breast cancer than simple models of a few driver mutations would suggest. Only very few, recurrent mutations or copy-number variations ...
  • Pállinger, Éva; Horváth, Zsuzsanna; Csóka, Monika; Kovács, Gábor; Csaba, György (2011)
    Histamine, serotonin and triiodothyronine (T3) content of different circulating lymphocyte subsets of leukemic (acute lymphocytic leukemia, ALL) and non-leukemic (control) children were investigated by multicolor flow ...
  • Vannay Ádám; Fekete Andrea; Langer Róbert; Tóth Tibor; Sziksz Erna; Vásárhelyi Barna; Szabó Attila J.; Losonczy, György; Ádori Csaba; Gál Anikó; Tulassay Tivadar; Szabó András (2009)
    Background: Beneficial effects of dehydroepiandrosterone (DHEA) pretreatment were reported in ischaemia/reperfusion (I/R)-induced kidney damage. Methods: To investigate the mechanism of DHEA pretreatment during renal I/R ...
  • McCann LJ; Pilkington CA; Huber AM; Ravelli A; Appelbe D; Kirkham JJ; Williamson PR; Aggarwal A; Christopher-Stine L; Constantin, Tamás; Feldman BM; Lundberg I; Maillard S; Mathiesen P; Murphy R; Pachman LM; Reed AM; Rider LG; van Royen-Kerkof A; Russo R; Spinty S; Wedderburn LR; Beresford MW (2018)
    Objectives This study aimed to develop consensus on an internationally agreed dataset for juvenile dermatomyositis (JDM), designed for clinical use, to enhance collaborative research and allow integration of data between ...
  • Constantin, Tamás; Foeldvari, I; Pain, CE; Palinkas, A; Hoger, P; Moll, M; Nemkova, D; Weibel, L; Laczkovszki, M; Clements, P; Torok, KS (2018)
    Juvenile localized scleroderma (jLS), also known as morphea, is an orphan disease. Pediatric guidelines regarding diagnosis, assessment, and management are lacking. Our objective was to develop minimum standards of care ...
  • van Zanten SE; Baugh J; Chaney B; De Jongh D; Aliaga ES; Barkhof F; Noltes J; De Wolf R; Van Dijk J; Cannarozzo A; Damen-Korbijn CM; Lieverst JA; Colditz N; Hoffmann M; Warmuth-Metz M; Bison B; Jones DT; Sturm D; Gielen GH; Jones C; Hulleman E; Calmon R; Castel D; Varlet P; Giraud G; Slavc I; Van Gool S; Jacobs S; Jadrijevic-Cvrlje F; Sumerauer D; Nysom K; Pentikainen V; Kivivuori SM; Leblond P; Entz-Werle N; von Bueren AO; Kattamis A; Hargrave DR; Hauser P; Garami, Miklós; Thorarinsdottir HK; Pears J; Gandola L; Rutkauskiene G; Janssens GO; Torsvik IK; Perek-Polnik M; Gil-da-Costa MJ; Zheludkova O; Shats L; Deak L; Kitanovski L; Cruz O; La Madrid AM; Holm S; Gerber N; Kebudi R; Grundy R; Lopez-Aguilar E; Zapata-Tarres M; Emmerik J; Hayden T; Bailey S; Biassoni V; Massimino M; Grill J; Vandertop WP; Kaspers GJ; Fouladi M; Kramm CM; van Vuurden DG; members of the SIOPE DIPG Network (2017)
    Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly childhood malignancy. After 40 years of mostly single-center, often non-randomized trials with variable patient inclusions, there has been no improvement in ...
  • Szegedi, István; Jakab, Zsuzsanna; Masát P; Kiss, Csongor; Hungarian Pediatric Hematology-Oncology Group (HPOG) (2013)
    Acute myeloid leukemias (AML) comprising approximately 15 % of pediatric leukemias account for 30 % of all leukemic deaths in children worldwide. The 5-year overall survival (OS) rate now reaches 60-65 % in Western Europe, ...